Glaucoma

5 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Lists the pairs whose condition is this category or one beneath it. A category is not a diagnosis and not advice.

Narrower: Glaucoma, Open-Angle 3

Treatments and conditions

Glaucoma
Treatment and conditionWhere it standsTrials
Bimatoprost ophthalmic solution 0.01% YSBP for glaucoma, open-anglePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Citicoline eye drops 2% for glaucoma, open-anglePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
ER-100 epigenetic therapy for glaucoma, open-anglePhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Kinezodianone R hydrochloride for glaucomaPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Nicotinamide riboside for glaucomaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1

Categories are from Medical Subject Headings (MeSH), U.S. National Library of Medicine, courtesy of the U.S. National Library of Medicine: MeSH. They may not reflect the most current data available from NLM. NLM does not endorse this site.